![]() |
Name |
Sclerotiamide B
|
Molecular Formula | C27H31N3O5 | |
IUPAC Name* |
(1'R,3R,7'S,9'S,12'S)-12'-methoxy-7,7,10',10'-tetramethylspiro[1H-pyrano[2,3-g]indole-3,11'-3,13-diazatetracyclo[5.5.2.01,9.03,7]tetradecane]-2,2',14'-trione
|
|
SMILES |
CC1(C=CC2=C(O1)C=CC3=C2NC(=O)[C@@]34[C@@H]([C@]56[C@H](C4(C)C)C[C@@]7(CCCN7C5=O)C(=O)N6)OC)C
|
|
InChI |
InChI=1S/C27H31N3O5/c1-23(2)11-9-14-16(35-23)8-7-15-18(14)28-21(32)26(15)19(34-5)27-17(24(26,3)4)13-25(20(31)29-27)10-6-12-30(25)22(27)33/h7-9,11,17,19H,6,10,12-13H2,1-5H3,(H,28,32)(H,29,31)/t17-,19-,25-,26-,27+/m0/s1
|
|
InChIKey |
KYOGJHMTXUTNJJ-WDMQBYORSA-N
|
|
Synonyms |
Sclerotiamide B
|
|
CAS | NA | |
PubChem CID | 146682810 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 477.6 | ALogp: | 1.7 |
HBD: | 2 | HBA: | 5 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 97.0 | Aromatic Rings: | 8 |
Heavy Atoms: | 35 | QED Weighted: | 0.648 |
Caco-2 Permeability: | -5.22 | MDCK Permeability: | 0.00002420 |
Pgp-inhibitor: | 0.993 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.136 | 20% Bioavailability (F20%): | 0.904 |
30% Bioavailability (F30%): | 0.934 |
Blood-Brain-Barrier Penetration (BBB): | 0.589 | Plasma Protein Binding (PPB): | 81.16% |
Volume Distribution (VD): | 0.926 | Fu: | 15.20% |
CYP1A2-inhibitor: | 0.01 | CYP1A2-substrate: | 0.384 |
CYP2C19-inhibitor: | 0.103 | CYP2C19-substrate: | 0.893 |
CYP2C9-inhibitor: | 0.361 | CYP2C9-substrate: | 0.066 |
CYP2D6-inhibitor: | 0.048 | CYP2D6-substrate: | 0.133 |
CYP3A4-inhibitor: | 0.888 | CYP3A4-substrate: | 0.918 |
Clearance (CL): | 5.837 | Half-life (T1/2): | 0.276 |
hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.708 |
Drug-inuced Liver Injury (DILI): | 0.884 | AMES Toxicity: | 0.689 |
Rat Oral Acute Toxicity: | 0.968 | Maximum Recommended Daily Dose: | 0.932 |
Skin Sensitization: | 0.215 | Carcinogencity: | 0.969 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.005 |
Respiratory Toxicity: | 0.728 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004946 | ![]() |
0.877 | D06HBQ | ![]() |
0.220 | ||
ENC002052 | ![]() |
0.854 | D06XZW | ![]() |
0.212 | ||
ENC004072 | ![]() |
0.780 | D00ETS | ![]() |
0.212 | ||
ENC002366 | ![]() |
0.718 | D03ZZK | ![]() |
0.209 | ||
ENC002534 | ![]() |
0.718 | D06YFA | ![]() |
0.207 | ||
ENC002536 | ![]() |
0.718 | D0C7JF | ![]() |
0.205 | ||
ENC002538 | ![]() |
0.693 | D0N0RU | ![]() |
0.201 | ||
ENC004945 | ![]() |
0.690 | D02JNM | ![]() |
0.201 | ||
ENC004944 | ![]() |
0.690 | D03SKD | ![]() |
0.200 | ||
ENC004948 | ![]() |
0.602 | D02IQY | ![]() |
0.200 |